Nav: Home

New options for treating autism

November 18, 2015

The researcher Olga Peñagarikano, a Ramón y Cajal researcher in the Department of Pharmacology at the UPV/EHU's Faculty of Medicine, and who has broad experience in the study of the neurobiological causes of autism and intervention in the oxytocin system as a potential treatment for this condition, has contributed towards a piece of research carried out by a team at the University of California, Irvine.

The Autism Spectrum Disorder (ASD) is mainly characterised by a deficit in social behaviour. Oxytocin, a natural hormone produced by the brain, is involved in social behaviour. There have been some clinical trials with humans in which it has been demonstrated that when the amount of oxytocin is increased, there are certain aspects that improve in social interactions. "Today there is as yet no treatment in autism to improve social behaviour, but one of the most promising therapies for ASD is intervention in the oxytocin system," explained the researcher.

It is believed that at least some of the patients with ASD could have a dysfunction in this system. In fact, in another recent publication, the researcher showed that a mouse autism model displayed reduced levels of oxytocin in the brain and that the administering of the hormone improved social behaviour. To do this, she built a viral vector -- a virus that has been modified so that it is not pathogenic, in other words, it does not cause any illness -- to transfer an artificial receptor to the neurons that produce oxytocin in the mouse. This technique, known as DREADD (Designer Receptors Exclusively Activated by Designer Drugs), is a widely used technique in the study of neuronal circuits: it consists of transferring an artificial receptor to the relevant neurons, which will be activated or disabled exclusively through the administering of a specific drug to study the effect.

Anandamide increases the preference for interacting socially

Dr Daniele Piomelli, a researcher at the University of California and expert in endocannabinoids, contacted Peñagarikano to be able to use the vector developed by this Basque researcher in the DREADD technique in a study that has served to demonstrate that the release of oxytocin leads to an increase in the production of anandamide (an endogenous substance produced by the body and which acts on the cannabinoid receptors, the same receptors on which cannabis acts). "My involvement in this work was to share the viral vector needed for the DREADD technique and to supervise its use and offer advice to ensure that it was used successfully," explained Peñagarikano.

The results obtained in the research suggest that one of the mechanisms by which oxytocin causes interpersonal relations to be perceived as pleasant could be through the release of anandamide. When the amount of anandamide was increased, the mice displayed a greater preference for interacting socially. When the oxytocin system is activated, both pharmacologically and through the DREADD technique, an increase in anandamide production occurs. Oxytocin is known to interact with other neurotransmitters in this system, such as serotonin and dopamine. This piece of work "reveals a new component in the system," concluded Peñagarikano, "which could have implications when it comes to developing drugs for conditions affected by impairments in social behaviour, such as autism, and based on the modulation of this circuit".
-end-
Additional information

Dr Olga Peñagarikano (Tolosa, Basque Country, 1974) recently (2015) joined the Department of Pharmacology at the UPV/EHU Faculty of Medicine as a Ramón y Cajal researcher. She spent 6 years working at the University of California, Los Angeles (UCLA) as a post-doctoral researcher. Her work focusses on studying the neurobiological causes of autism in order to come up with treatments, and right now she is exploring intervention in the oxytocin system as a potential treatment for autism in a project being funded by the Brain and Behavior Research Foundation in the United States (formerly NARSAD).

Bibliographical reference

Don Wei, DaYeon Lee, Conor D. Cox, Carley A. Karsten, Olga Peñagarikano, Daniel H. Geschwind, Christine M. Gall, Daniele Piomelli. "Endocannabinoid signaling mediates oxytocin-driven social reward". PNAS. Published online before print on Oct. 26, 2015.

University of the Basque Country

Related Autism Articles:

Genes, ozone, and autism
Exposure to ozone in the environment puts individuals with high levels of genetic variation at an even higher risk for developing autism than would be expected just by adding the two risk factors together, a new analysis shows.
A blood test for autism
An algorithm based on levels of metabolites found in a blood sample can accurately predict whether a child is on the autism spectrum of disorder (ASD), based upon a recent study.
New form of autism found
Autism spectrum disorders (ASD) affect around one percent of the world's population and are characterized by a range of difficulties in social interaction and communication.
Autism Speaks MSSNG study expands understanding of autism's complex genetics
A new study from Autism Speaks' MSSNG program expands understanding of autism's complex causes and may hold clues for the future development of targeted treatments.
Paths to Autism: One or Many?
A new report in Biological Psychiatry reports that brain alterations in infants at risk for autism may be widespread and affect multiple systems, in contrast to the widely held assumption of impairment specifically in social brain networks.
More Autism News and Autism Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...